Scientists and policymakers are grappling with the mysteries of UAPs, with figures like Avi Loeb suggesting nonhuman observers may study us and SETI's Bill Diamond calling for scientific rigor. Public interest, driven by cultural mythology and national security concerns, fuels calls for transparency and investigation, as most Americans believe in the possibility of extraterrestrial life, suggesting a need for openness in UAP data.

Artemis II will perform a historic fly-by of the Moon's far side on April 6, marking the first human visit since 1972. The mission aims to observe key geological features like the Orientale basin, enhancing our understanding of lunar geology through direct human observation.

MIT researchers have developed a scalable technique for producing moiré crystals, unlocking new possibilities for exploring higher-dimensional quantum phenomena. This advancement could revolutionize quantum technology by simulating four-dimensional behavior in electrons, expanding the scope of electronic applications.

Researchers have developed BK-TriGs, injectable hydrogels that enhance clotting in neonates, potentially reducing surgical bleeding. Studies show these gels improve clotting in infant plasma, with further safety evaluations underway.

Gladstone Institutes' researchers found a link between APOE4 and early Alzheimer’s brain changes, with Nell2 as a key mediator. Lowering Nell2 levels in mice reversed neuronal alterations, suggesting a new therapeutic target for early intervention.

A groundbreaking study across 34 countries reveals that brain aging is significantly influenced by a combination of environmental, social, and political factors. The research highlights the need for comprehensive policy reforms targeting pollution reduction, urban planning, and social protection to mitigate the effects on brain health.

GLP-1 receptor agonists, like semaglutide, have revolutionized obesity treatment with significant weight loss and cardiovascular benefits, but concerns over long-term safety and access persist. Medicare expanded coverage for these medications in 2026, yet high costs and insurance barriers continue to limit accessibility, especially for lower-income and minority groups.

A UCLA review reveals significant gaps in preventive healthcare for diabetic women compared to non-diabetic peers, notably in cancer screenings and contraceptive counseling. Researchers recommend leveraging electronic health records and team-based care models to improve service uptake, highlighting a need for integrative, patient-centered approaches.

Canada faces its highest meningococcal disease surge in over a decade, with cases spiking from 48 in 2021 to 155 in 2025, and 63 reported this year already. Experts warn about severe outcomes and stress vaccination as crucial, amid varied regional vaccine access.

The Wistar Institute appoints Dr. Mamedov as Assistant Professor to advance cancer immunotherapy research using gamma-delta T cells. His work will leverage CRISPR genome editing to identify new therapeutic targets, reflecting Wistar's focus on innovative cancer and immunology solutions.

Columbia University students have launched Moby Filter, a startup tackling microplastic pollution from laundry, with NOAA and university backing. This venture turns academic research into practical solutions, aiming to scale and influence global microfiber regulations.

Low-carbon aluminum recycling, which significantly reduces energy use and emissions compared to primary production, is gaining traction globally with varied regional infrastructure and maturity. By 2035, technology evolution and substantial investment will be crucial for scaling capacity, while strategic sourcing and processing innovations will address contamination challenges in scrap sources.

A study reveals 20% of children in northern Imperial Valley suffer from asthma, linked to dust exposure from the shrinking Salton Sea. The research urges California to prioritize air quality and health measures amid climate challenges and development projects affecting low-income Latino communities.

Cornell researchers have enhanced the MAGIC toolkit, enabling comprehensive genome-wide, single-cell resolution studies in Drosophila. This advancement accelerates research in development, neuroscience, and disease by allowing large-scale genetic screens and facilitating the study of complex gene functions without specialized training.

The Bay in the Balance 2026 conference highlighted significant strides in Chesapeake Bay conservation, with Pennsylvania cutting over five million pounds of nitrogen pollution since 2019. Despite advancements through peer learning and technology, challenges like funding and data gaps persist, necessitating continued collaboration across the watershed.

HER2-low cells are found to drive resistance to antibody-drug conjugates (ADCs) but remain sensitive to HER2 tyrosine kinase inhibitors (TKIs), suggesting alternative or combination treatment strategies. Preclinical studies reveal combining USP9X inhibitors with T-DXd could improve outcomes, although further human trials are necessary to validate these findings and assess safety.

Datopotamab deruxtecan (Dato-DXd) significantly outperforms standard chemotherapy for first-line treatment of advanced TNBC, extending progression-free survival from 5.6 to 10.8 months. The TROPION-Breast02 trial highlights Dato-DXd's safety profile and potential as a new non-immunotherapy standard, offering meaningful clinical benefits despite some adverse effects.

University of Chicago students discovered one of the oldest and most metal-poor stars, SDSSJ0715-7334, using Gaia and SDSS data. The star's journey from the Large Magellanic Cloud to the Milky Way highlights its ancient origins, providing insightful implications for cosmic history research.

Aging deteriorates the lymphatic system, impairing capillary density, valve function, and lymph node integrity, leading to increased systemic inflammation and neurodegenerative risks. Current treatments, including drugs and surgery, aim to counteract these effects, but success in humans remains limited, highlighting the need for further research into effective therapies.